Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Muscle Neoplasms × Tumor Necrosis Factor-alpha × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Neoplasms 1 Muscle Neoplasms 1 HIV Infections 1 Acquired Immunodeficiency Syndrome 1 AIDS-Related Complex 1

Interventions

Tumor Necrosis Factor-alpha 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00019968 2023-10-31

Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

Neoplasms, Sarcoma, Muscle Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡